Literature DB >> 36035565

Diagnosis and Treatment of Bipolar Illness in the Primary Care Office.

Jay A Brieler1, Elizabeth Keegan-Garrett2.   

Abstract

Bipolar Affective Disorder (BPAD) is frequently encountered in the primary care office and must be considered in the differential diagnosis of all patients with mood dysregulation. Appreciation for the range of bipolar illness has evolved in recent years, and the overlap of bipolar illness with trauma-based diagnosis such as Post-Traumatic Stress Disorder (PTSD) and Borderline Personality Disorder must be considered. Treatment of BPAD is divided into manic, depressive, and maintenance phases, each with different pharmacologic considerations. First line agents for the acute manic phase include lithium, valproic acid, and second generation antipsychotics (SGAs). First line agents for depressive phase include lamotrigine, lithium, and the SGAs lurasidone and quetiapine. For bipolar maintenance therapy, lamotrigine, valproic acid, and lithium are first line options. Finally, nonpharmacologic interventions including psychoeducation can be extremely helpful for patients and their families to successfully participate in the management of their disease. Copyright 2022 by the Missouri State Medical Association.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36035565      PMCID: PMC9324725     

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  30 in total

1.  Practice guideline for the treatment of patients with bipolar disorder (revision).

Authors: 
Journal:  Am J Psychiatry       Date:  2002-04       Impact factor: 18.112

2.  Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.

Authors:  Antony Loebel; Josephine Cucchiaro; Robert Silva; Hans Kroger; Kaushik Sarma; Jane Xu; Joseph R Calabrese
Journal:  Am J Psychiatry       Date:  2014-02       Impact factor: 18.112

Review 3.  Towards recovery-oriented psychosocial interventions for bipolar disorder: Quality of life outcomes, stage-sensitive treatments, and mindfulness mechanisms.

Authors:  Greg Murray; Nuwan D Leitan; Neil Thomas; Erin E Michalak; Sheri L Johnson; Steven Jones; Tania Perich; Lesley Berk; Michael Berk
Journal:  Clin Psychol Rev       Date:  2017-01-17

4.  A primary care guide to bipolar depression treatment.

Authors:  Nagy A Youssef; Emily Aquadro; Andria Thomas; Shilpa Brown; Kate O'Connor; Joseph Hobbs; Ram J Bishnoi
Journal:  J Fam Pract       Date:  2020-09       Impact factor: 0.493

Review 5.  The psychopharmacology algorithm project at the Harvard South Shore Program: an algorithm for acute mania.

Authors:  Othman Mohammad; David N Osser
Journal:  Harv Rev Psychiatry       Date:  2014 Sep-Oct       Impact factor: 3.732

6.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

Authors:  Lakshmi N Yatham; Sidney H Kennedy; Sagar V Parikh; Ayal Schaffer; David J Bond; Benicio N Frey; Verinder Sharma; Benjamin I Goldstein; Soham Rej; Serge Beaulieu; Martin Alda; Glenda MacQueen; Roumen V Milev; Arun Ravindran; Claire O'Donovan; Diane McIntosh; Raymond W Lam; Gustavo Vazquez; Flavio Kapczinski; Roger S McIntyre; Jan Kozicky; Shigenobu Kanba; Beny Lafer; Trisha Suppes; Joseph R Calabrese; Eduard Vieta; Gin Malhi; Robert M Post; Michael Berk
Journal:  Bipolar Disord       Date:  2018-03-14       Impact factor: 6.744

Review 7.  Bipolar disorders.

Authors:  Roger S McIntyre; Michael Berk; Elisa Brietzke; Benjamin I Goldstein; Carlos López-Jaramillo; Lars Vedel Kessing; Gin S Malhi; Andrew A Nierenberg; Joshua D Rosenblat; Amna Majeed; Eduard Vieta; Maj Vinberg; Allan H Young; Rodrigo B Mansur
Journal:  Lancet       Date:  2020-12-05       Impact factor: 79.321

Review 8.  What is the impact of mental health-related stigma on help-seeking? A systematic review of quantitative and qualitative studies.

Authors:  S Clement; O Schauman; T Graham; F Maggioni; S Evans-Lacko; N Bezborodovs; C Morgan; N Rüsch; J S L Brown; G Thornicroft
Journal:  Psychol Med       Date:  2014-02-26       Impact factor: 7.723

Review 9.  Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials.

Authors:  John R Geddes; Joseph R Calabrese; Guy M Goodwin
Journal:  Br J Psychiatry       Date:  2009-01       Impact factor: 9.319

10.  The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders.

Authors:  Isabella Pacchiarotti; David J Bond; Ross J Baldessarini; Willem A Nolen; Heinz Grunze; Rasmus W Licht; Robert M Post; Michael Berk; Guy M Goodwin; Gary S Sachs; Leonardo Tondo; Robert L Findling; Eric A Youngstrom; Mauricio Tohen; Juan Undurraga; Ana González-Pinto; Joseph F Goldberg; Ayşegül Yildiz; Lori L Altshuler; Joseph R Calabrese; Philip B Mitchell; Michael E Thase; Athanasios Koukopoulos; Francesc Colom; Mark A Frye; Gin S Malhi; Konstantinos N Fountoulakis; Gustavo Vázquez; Roy H Perlis; Terence A Ketter; Frederick Cassidy; Hagop Akiskal; Jean-Michel Azorin; Marc Valentí; Diego Hidalgo Mazzei; Beny Lafer; Tadafumi Kato; Lorenzo Mazzarini; Anabel Martínez-Aran; Gordon Parker; Daniel Souery; Ayşegül Ozerdem; Susan L McElroy; Paolo Girardi; Michael Bauer; Lakshmi N Yatham; Carlos A Zarate; Andrew A Nierenberg; Boris Birmaher; Shigenobu Kanba; Rif S El-Mallakh; Alessandro Serretti; Zoltan Rihmer; Allan H Young; Georgios D Kotzalidis; Glenda M MacQueen; Charles L Bowden; S Nassir Ghaemi; Carlos Lopez-Jaramillo; Janusz Rybakowski; Kyooseob Ha; Giulio Perugi; Siegfried Kasper; Jay D Amsterdam; Robert M Hirschfeld; Flávio Kapczinski; Eduard Vieta
Journal:  Am J Psychiatry       Date:  2013-11       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.